Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Nasser K AltorkiZachary H WalshJohannes C MelmsJeffery L PortBenjamin E LeeAbu NasarCathy SpinelliLindsay CaprioMeri RogavaPatricia HoPaul J ChristosAshish SaxenaOlivier ElementoBhavneet BhinderCasey AgerAmit Dipak AminNicholas J SanfilippoVivek MittalAlain C BorczukSylvia C FormentiBenjamin IzarTimothy E McGrawPublished in: Nature communications (2024)